Company: HURA
Filing Date: 2025-02-07
Form Type: S-4
Source: 0001193125-25-022803
Chunk: 844

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-02-07
Form: S-4
Chunk 844
---
 a provision which requires the capitalization of Section 174 costs incurred in years beginning on or after January 1, 2022. Section 174 costs are expenditures which represent research and development costs that are incident to the development or improvement of a product, process, formula, invention, computer software, or technique. This provision changes the treatment of Section 174 costs such that the expenditures are no longer allowed as an immediate deduction but rather must be capitalized and amortized. The Company has included the impact of this provision, which results in a deferred tax asset of approximately $4.4 million as of December 31, 2023 and approximately $3.6 million as of December 31, 2022. On August 16, 2022, the Inflation Reduction Act (“IRA”) was enacted into US law. Effective for tax years beginning after December 31, 2022, the IRA imposes a 15% corporate minimum tax, a 1% excise tax on share repurchases, and creates and extends certain tax-relatedenergy incentives. Management does not expect the tax-relatedprovisions of the IRA to have a material impact on the Company’s consolidated financial statements. Unrecognized Tax Benefits The unrecognized tax benefits, if recognized, would not have an impact on the Company’s effective tax rate assuming the Company continues to maintain a full valuation allowance position. As of December 31, 2023, no significant increases or decreases are expected to the Company’s uncertain tax positions within the next twelve months.

|                                                                |     | Years Ended    
 December 31,   
 2023           
 (in thousands) |       |     | 2022 |     |
|:---------------------------------------------------------------|:----|:---------------|------:|:----|:-----|----:|
| Beginning balance of unrecognized tax benefits                 |     | $              |   828 |     | $    | 630 |
| Gross increases based on tax positions related to current year |     |                |   172 |     |      | 198 |
| Ending balance of unrecognized tax benefits                    |     | $              | 1,000 |     | $    | 828 |

F-115

KINETA, INC. Notes to Consolidated Financial Statements Interest and penalties related to the Company’s unrecognized tax benefits accrued as of December 31, 2023 were not material. The Company does not expect its uncertain tax positions to have material impact on its consolidated financial statements within the next twelve months. All of the unrecognized tax benefits as